食管癌中医证型分布与中药治疗研究进展  

Research Progress of TCM Syndrome Types and Treatment of Esophageal Cancer

作　　者：刘洁[1] 李立平[1] 赵亚刚[1] 

机构地区：[1]广州军区总医院消化内科,广东广州510010

出　　处：《中华中医药学刊》2017年第7期1772-1774,共3页Chinese Archives of Traditional Chinese Medicine

基　　金：国家自然科学基金青年科学基金项目(81302164)

摘　　要：对近5年来食管癌的中医证型分布及中药治疗进行整理,系统的总结了目前食管癌中医证型分布与中药治疗研究进展。目前,食管癌死亡率高,但是随着对其不断深入的研究,在食管癌中医证型分布及中药治疗上取得了一定的进展。食管癌辨证分型主要分为痰气互阻型、血瘀痰滞型、阴虚热毒型、气虚阳微型及脾虚气滞型。中医药辨证论治可提高食管癌治疗效果,紫衫醇、牡荆苷、宝霍苷、汉防己甲素、雷公藤素均可用于食管癌临床辨证论治中,以提高治疗效果。We collected the traditional Chinese medicine syndromes of esophageal cancer tbr the past five years and systematically summarize the current research progress. Currently, the mortality rate of esophageal cancer is high, but with the deepening of its research, we have made some progress on TCM syndrome distribution and traditional Chinese medicine treatment. Esophageal syndromes are divided into phlegm - Qi inter - obstruction type, phlegm and blood stasis type, toxic heat and Yin deficiency type, Qi deficiency and Yang weakness type and spleen deficiency and Qi stagnation type. Chinese medicine syndrome differentiation can improve the therapeutic effect of esophageal cancer. Paelitaxel, Vi- texin, baohuoside I , Tetrandrine and Tripterygium wilfordii can be used for clinical diagnosis and treatment of esophageal cancer in order to improve the therapeutic effect.

关 键 词：食管癌 紫衫醇 牡荆苷 宝霍苷 汉防己甲素 雷公藤素 

分 类 号：R735[医药卫生—肿瘤]